⌘K
OverviewStock screenerAnalyst actionsTicker roomsCalendar
MarketsInvestorsSign in
StockUnited StatesNasdaqGS

BEAM

Beam Therapeutics Inc.

Healthcare · Biotechnology

24.05USD

-0.5100 (-2.08%)

Alert
DescriptionHistoricalFinancialsRelative ValueResearchNewsCommunityRoomOptionsPrice Chart ↗Fundamental Chart ↗
ProfileRatiosRevenue & EPS
Reading financial statements from SEC filings…
A first visit to a security takes a few seconds.

Community sentiment

Not enough data yet

A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.

Sign in to share your take on BEAM.

Members' own stated views, weighted by account age and track record on this site (simulated portfolios and calls). Not a forecast or a price signal. How this is worked out
  • Only members whose accounts are at least 14 days old and who have a track record on this site (simulated portfolios and calls) count, and bots never do. A take from anyone else is saved and starts to count the day they qualify.
  • A take fades: it counts half as much after 7 days and drops out after 30.
  • Members with a strong record count more. Everyone else counts together for a capped share, so many accounts cannot outweigh a few strong ones.
  • Nothing is shown until 5 qualifying members have taken part, 2 of them with a strong record. It stays an early read until 3 have one and the sample is large enough.
  • Until 20 members have taken part the marker only says bullish, bearish or mixed, at a fixed spot, and the number of members is given as a band, not a count.
  • The reading is refreshed about every 30 minutes, so a take you have just made will not move it straight away.
  • Your own take is private: only the totals are shown, and never who said what.
Fiscal Year End12/2025
Last Quarter End06/2026 Q2
Current/T12M(USD)
1)

Issue Data

Last PxUSD / 24.05
P/E—
Dvd Ind Yld0.0%
P/B2.33
P/S15.9
Curr EV/T12M EBITDA-4.2
Mkt Cap (USD)2.5B
Curr EV (USD)1.5B
2)

Per Share Data

EPS T12M-0.72
DPS—
Bk Val Per Sh10.69
Rev/Sh1.50
Cash/Sh11.54
Curr Shares Out103.3M
FCF/Sh-3.57
3)

Cash Flow Analysis

P/CF-6.9
Curr P/FCF-6.7
CF/NI4.2
Dvd P/O—
Cash Gen/Cash Reqd—
Csh Dvd Cov—
CFO/Sales-230.3%
Eff Interest Rate—
4)

Growth Potential

Dil EPS 1Y Gr82.3%
Cap 1Y Gr68.8%
BPS 1Y Gr40.5%
R&D To Sales261.9%
Retention Rate—
Rev 1Y Gr120.0%
FCF 1Y Gr-1.1%
Assets 1Y Gr34.2%
5)

Profitability

EBITDA-0.4B
EBIT-0.4B
Operating Margin-242.3%
Pretax Margin-39.1%
Net Margin-54.7%
ROA-6.2%
ROE-8.1%
ROC-28.8%
Asset Turnover0.11
6)

Structure

Current Ratio14.57
Quick Ratio14.25
Debt/Assets17.8%
Debt/Com Eq23.2%
Net Debt/EBITDA-0.08
Tot Debt/Capital18.8%
Gross Margin-161.9%
EBIT/Int Exp—

Returns and turnover use the AVERAGE balance over the year, not the closing snapshot. Growth rates compare the two most recent fiscal years.